Methotrexate is associated with decreased total thyroxine in patients with rheumatoid arthritis.

Shu-Lin ChenQiang XuChang-Song Lin

Published in: Inflammopharmacology (2023)

Methotrexate is associated with decreased TT4 levels in RA patients, and glucocorticoids is associated with decreased TT3 levels. Drugs of RA treatment may affect the thyroid function of patients while treating RA, which may be one of the causes of secondary thyroid diseases in RA patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
rheumatoid arthritis
chronic kidney disease
prognostic factors
patient reported outcomes
systemic lupus erythematosus
high dose
systemic sclerosis